Key topics discussed included implications of guanine quadruplex‐structured DNA in tau pathology, maladaptive translation processes in tauopathies, leveraging genetic code expansion for expression and purification of hyperphosphorylated tau, and intracellular degradation pathways of tau, as summarized below. The gene discussed is MAPT; the disease is tauopathy.